ARCHIVES

Colon Cancer Survival Rates Differ Across Racial Lines

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

Bristol To Support Grants For Studies On Drug Resistance

June 26, 1987

New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors

April 4, 1980

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

Upton Tells Press He Wasn’t Hired To Push Prevention

August 5, 1977

RFA For Patterns Of Care Study in Elderly Issues

January 14, 1983